Global Atherectomy Devices Market Size study & forecast, by Product (Rotational Atherectomy Devices, Orbital Atherectomy Devices, Directional Atherectomy Devices) by End User (Hospitals, Ambulatory surgery centers) and Regional Analysis, 2022-2029

Global Atherectomy Devices Market Size study & forecast, by Product (Rotational Atherectomy Devices, Orbital Atherectomy Devices, Directional Atherectomy Devices) by End User (Hospitals, Ambulatory surgery centers) and Regional Analysis, 2022-2029

Global Atherectomy Devices Market is valued approximately USD XXX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. Atherectomy devices are medical devices that are used to remove or modify atherosclerotic plaque build-up from arteries. Atherosclerosis is a condition in which fatty deposits, cholesterol, and other substances accumulate inside the walls of arteries, leading to narrowing and hardening of the vessels. Atherectomy devices are designed to physically remove or reduce the plaque, thereby improving blood flow to the affected area. Atherectomy devices can be used to treat blockages in various parts of the body, including the coronary arteries, carotid arteries, and peripheral arteries. These devices work by using various techniques such as cutting, grinding, or vaporizing the plaque, and some devices also use suction to remove the debris. The key factor driving the market growth is rising prevalence of peripheral artery disease (PAD), growing demand for minimally invasive procedures, and continuous product development and commercialization that anticipated to create the lucrative demand for the market during forecast period.

However, the prevalence of peripheral artery disease (PAD) is anticipated to support the market growth. According to Statista, in 2019, the revenue of global peripheral artery disease market was USD 4.53 billion and the number is anticipated to reach USD 8.78 billion by 2030. As a result, the rising global peripheral artery disease market is represent the rising prevalence of peripheral artery disease which support the market growth during forecast period. Additionally, the rising technological advancement in atherectomy devices is anticipated to create the lucrative opportunity for the market. However, the limited availability of skilled healthcare professionals’ stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Atherectomy Devices Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the dominating region across the world in terms of market share, owing to the rise in adoption of atherectomy devices by patients, increase in awareness about the peripheral artery disease, and surge in healthcare infrastructure. Whereas, Asia Pacific is also anticipated to exhibit highest growth rate over the forecast period, owing to factors such as rise in per capita spending, growth in medical tourism, and growing disposable incomes would create lucrative growth prospects for the Atherectomy Devices market across Asia Pacific region.

Major market player included in this report are:
Medtronic plc
Koninklijke Philips N.V.
Boston Scientific Corporation
Cardiovascular Systems, Inc.
Becton
Dickinson and Company
AngioDynamics Inc.
Rex medical
Nipro Corporation
Invamed medical
Avinger Inc.

Recent Developments in the Market:
In February 2022, RA Medical Systems, revealed that enrollment has reached 95 subjects in the pivotal clinical trial to analyze the safety and effectiveness of the DABRA organic light emitting laser system as an atherectomy device for the diagnosis of peripheral arterial disease.
Global Atherectomy Devices Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Product, End User, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players.

The detailed segments and sub-segment of the market are explained below:

By Product:
Rotational Atherectomy Devices
Orbital Atherectomy Devices
Directional Atherectomy Devices

By End User:
Hospitals
Ambulatory surgery centers

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World

Companies Mentioned

Medtronic plc
Koninklijke Philips N.V.
Boston Scientific Corporation
Cardiovascular Systems, Inc.
Becton
Dickinson and Company
AngioDynamics Inc.
Rex medical
Nipro Corporation
Invamed medical
Avinger Inc.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.